Pilot Compassionate Use Study of Thioctic Acid Treatment in Mitochondrial Myopathy
I. Assess the efficacy of thioctic acid in treating a single patient with mitochondrial myopathy.
|Study Design:||Endpoint Classification: Efficacy Study
Primary Purpose: Treatment
|Study Start Date:||October 1995|
PROTOCOL OUTLINE: The patient receives one thioctic acid tablet 3 times a day. If patient experiences no side effects after 1 week, 2 tablets are administered and given 3 times a day over 3 months for compassionate use.
The patient is followed at weeks 3, 8, and 12.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00004770
|Study Chair:||Robert Griggs||University of Rochester|